Literature DB >> 25530083

The effect of iron in MRI and transverse relaxation of amyloid-beta plaques in Alzheimer's disease.

Mark D Meadowcroft1, Douglas G Peters, Rahul P Dewal, James R Connor, Qing X Yang.   

Abstract

Dysregulation of neural iron is known to occur during the progression of Alzheimer's disease. The visualization of amyloid-beta (Aβ) plaques with MRI has largely been credited to rapid proton relaxation in the vicinity of plaques as a result of focal iron deposition. The goal of this work was to determine the relationship between local relaxation and related focal iron content associated with Aβ plaques. Alzheimer's disease (n=5) and control tissue (n=3) sample slices from the entorhinal cortex were treated overnight with the iron chelator deferoxamine or saline, and microscopic gradient-echo MRI datasets were taken. Subsequent to imaging, the same slices were stained for Aβ and iron, and then compared with regard to parametric R2 * relaxation maps and gradient-echo-weighted MR images. Aβ plaques in both chelated and unchelated tissue generated MR hypo-intensities and showed relaxation rates significantly greater than the surrounding tissue. The transverse relaxation rate associated with amyloid plaques was determined not to be solely a result of iron load, as much of the relaxation associated with Aβ plaques remained following iron chelation. The data indicate a dual relaxation mechanism associated with Aβ plaques, such that iron and plaque composition synergistically produce transverse relaxation.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alzheimer's disease; Aβ; MRI; amyloid-beta; chelation; deferoxamine; iron; plaques

Mesh:

Substances:

Year:  2014        PMID: 25530083      PMCID: PMC4526111          DOI: 10.1002/nbm.3247

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  47 in total

1.  Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain.

Authors:  T M Wengenack; D A Reyes; G L Curran; B J Borowski; J Lin; G M Preboske; S S Holasek; E J Gilles; R Chamberlain; M Marjanska; C R Jack; M Garwood; J F Poduslo
Journal:  Neuroimage       Date:  2010-08-20       Impact factor: 6.556

Review 2.  The Haber-Weiss cycle--70 years later.

Authors:  W H Koppenol
Journal:  Redox Rep       Date:  2001       Impact factor: 4.412

3.  Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results.

Authors:  Andreas Deistung; Alexander Rauscher; Jan Sedlacik; Jörg Stadler; Stephan Witoszynskyj; Jürgen R Reichenbach
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

4.  Susceptibility weighted imaging with multiple echoes.

Authors:  Christian Denk; Alexander Rauscher
Journal:  J Magn Reson Imaging       Date:  2010-01       Impact factor: 4.813

5.  Redox cycling of iron by Abeta42.

Authors:  Ayesha Khan; Jon P Dobson; Christopher Exley
Journal:  Free Radic Biol Med       Date:  2005-10-14       Impact factor: 7.376

6.  MRI artifacts in human brain tissue after prolonged formalin storage.

Authors:  Sara van Duijn; Rob J A Nabuurs; Sanneke van Rooden; Marion L C Maat-Schieman; Sjoerd G van Duinen; Mark A van Buchem; Louise van der Weerd; Remco Natté
Journal:  Magn Reson Med       Date:  2011-02-08       Impact factor: 4.668

Review 7.  Metals and amyloid-beta in Alzheimer's disease.

Authors:  Christa J Maynard; Ashley I Bush; Colin L Masters; Roberto Cappai; Qiao-Xin Li
Journal:  Int J Exp Pathol       Date:  2005-06       Impact factor: 1.925

Review 8.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

Review 9.  Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species.

Authors:  Gemma Casadesus; Mark A Smith; Xiongwei Zhu; Gjumrakch Aliev; Adam D Cash; Kazuhiro Honda; Robert B Petersen; George Perry
Journal:  J Alzheimers Dis       Date:  2004-04       Impact factor: 4.472

10.  Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue.

Authors:  D Hautot; Q A Pankhurst; N Khan; J Dobson
Journal:  Proc Biol Sci       Date:  2003-08-07       Impact factor: 5.349

View more
  9 in total

Review 1.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

Review 2.  The Role of Microglia in Alzheimer's Disease From the Perspective of Immune Inflammation and Iron Metabolism.

Authors:  Hui-Zhi Long; Zi-Wei Zhou; Yan Cheng; Hong-Yu Luo; Feng-Jiao Li; Shuo-Guo Xu; Li-Chen Gao
Journal:  Front Aging Neurosci       Date:  2022-06-30       Impact factor: 5.702

Review 3.  Microbiota impacts on chronic inflammation and metabolic syndrome - related cognitive dysfunction.

Authors:  María Arnoriaga-Rodríguez; José Manuel Fernández-Real
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

4.  Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease.

Authors:  Zohara Sternberg; Zihua Hu; Daniel Sternberg; Shayan Waseh; Joseph F Quinn; Katharine Wild; Kaye Jeffrey; Lin Zhao; Michael Garrick
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

5.  Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.

Authors:  James Everett; Joanna F Collingwood; Vindy Tjendana-Tjhin; Jake Brooks; Frederik Lermyte; Germán Plascencia-Villa; Ian Hands-Portman; Jon Dobson; George Perry; Neil D Telling
Journal:  Nanoscale       Date:  2018-07-05       Impact factor: 7.790

6.  Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology.

Authors:  Martha Clare Morris; Ashley I Bush; Scott Ayton; Yamin Wang; Ibrahima Diouf; Julie A Schneider; John Brockman
Journal:  Mol Psychiatry       Date:  2019-02-18       Impact factor: 15.992

7.  A novel approach to quantify different iron forms in ex-vivo human brain tissue.

Authors:  Pravin Kumar; Marjolein Bulk; Andrew Webb; Louise van der Weerd; Tjerk H Oosterkamp; Martina Huber; Lucia Bossoni
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

8.  Quantitative comparison of different iron forms in the temporal cortex of Alzheimer patients and control subjects.

Authors:  Marjolein Bulk; Louise van der Weerd; Wico Breimer; Nikita Lebedev; Andrew Webb; Jelle J Goeman; Roberta J Ward; Martina Huber; Tjerk H Oosterkamp; Lucia Bossoni
Journal:  Sci Rep       Date:  2018-05-02       Impact factor: 4.379

9.  T2 heterogeneity: a novel marker of microstructural integrity associated with cognitive decline in people with mild cognitive impairment.

Authors:  Alfie R Wearn; Volkan Nurdal; Esther Saunders-Jennings; Michael J Knight; Hanna K Isotalus; Serena Dillon; Demitra Tsivos; Risto A Kauppinen; Elizabeth J Coulthard
Journal:  Alzheimers Res Ther       Date:  2020-09-10       Impact factor: 6.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.